Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2024

Mar 6, 2024

34129_dirs_2024-03-06_c8b9736d-7bd5-4c3c-9888-6a1d94d8637a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-03-04

Reporting Person: Karrels James (SVP, CFO and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-04 Common Stock S 30000 $20.50 Disposed 171452 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/7/2022.

F2: Owned jointly with reporting person's wife.